Bausch Health Companies

Yahoo Finance • 11 hours ago

BHC Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Bausch Health Companies Inc (Symbol: BHC) crossed below their 200 day moving average of $6.50, changing hands as low as $6.40 per share. Bausch Health Companies Inc shares are currently trading down about... Full story

Yahoo Finance • 2 days ago

TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors

TruTechnologies announced Jordan Zwick joined its Board of Directors. DURHAM, N.C., September 24, 2025--(BUSINESS WIRE)--TruTechnologies, a leading provider of real-time clinical trial oversight, today announced Jordan Zwick joined its Bo... Full story

Yahoo Finance • 5 days ago

How the FDA Is Taking Aim at the Surreal World of TV Drug Ads

The agency’s crackdown represents a significant rise in scrutiny of pharmaceutical ads in recent years. Continue Reading View Comments... Full story

Yahoo Finance • 10 days ago

Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bausch Health Companies is one of them. Bausch Health Companies Inc. (NYSE:BHC), a global specialty pharmaceutical company, has recently gained attent... Full story

Yahoo Finance • 17 days ago

North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL

Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "North America Intraocular Lens Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The North Americ... Full story

Yahoo Finance • 28 days ago

Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition

We recently compiled a list of the 10 Overlooked Healthcare Stocks to Invest in. Bausch Health Companies Inc. is one of them. Bausch Health Companies Inc. (NYSE:BHC) is a global specialty pharmaceutical and medical device company focused... Full story

Yahoo Finance • last month

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) today announced that BHC Lyon Merger Sub... Full story

Yahoo Finance • last month

Earnings call transcript: Bausch Health Q2 2025 sees revenue growth, stock dips

Bausch Health Companies Inc. (BHC) reported its Q2 2025 earnings, showcasing a strong revenue performance but experiencing a notable dip in stock price. The company reported earnings per share (EPS) of $0.40, significantly surpassing forec... Full story

Yahoo Finance • last month

Icahn representations resign Bausch + Lomb board after agreement termination

(Reuters) -Contact lens maker Bausch + Lomb said on Monday Brett Icahn and Gary Hu have resigned from its board of directors after the termination of the agreement with billionaire investor Carl Icahn and some of his affiliates. The agree... Full story

Yahoo Finance • last month

Paulson Capital increases stake in Bausch Health to 19.13%

NEW YORK - Paulson Capital Inc. and its affiliates have acquired the 34.7 million common shares previously held by Carl C. Icahn and his affiliates in Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), according to a company statement relea... Full story

Yahoo Finance • last month

Bausch Health rises after $300M worth insider purchase

[Bausch Health US headquarters in Bridgewater, NJ, USA.] JHVEPhoto/iStock Editorial via Getty Images Bausch Health (NYSE:BHC [https://seekingalpha.com/symbol/BHC]) shares added ~4% on Friday after John Paulson, a board member of the Canad... Full story

Yahoo Finance • last month

Paulson John buys $312 million in Bausch Health (BHC) shares

Director John Paulson reported purchasing 34,721,118 shares of Bausch Health Companies Inc. (NASDAQ:BHC) on August 14, 2025. The shares were bought at a price of $9.0, totaling approximately $312,490,062. The stock, currently trading at $7... Full story

Yahoo Finance • last month

Paulson & Co.'s top Q2 move is a new stake in Alphabet

[Google Cloud] 400tmax/iStock Unreleased via Getty Images Investment firm Paulson & Co. made only a handful of equity moves in Q2 2025, with the top play being a new position in Alphabet (NASDAQ:GOOGL [https://seekingalpha.com/symbol/GOOG... Full story

Yahoo Finance • last month

United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "United States Epilepsy Drugs Market - Therapeutic Landscape & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Epilepsy Drugs Market is expec... Full story

Yahoo Finance • last month

Vitiligo Treatment Strategic Market Research Report 2025-2030 | Increased Psychological and Social Impact of Vitiligo Drives Demand for More Effective Therapies

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Vitiligo Treatment was estimated at US$1.5 Billion in 20... Full story

Yahoo Finance • last month

Tesla and Monday Lead Market Cap Stock Movers on Monday

Monday’s trading session has brought significant movements across the board, with Tesla Motors (NASDAQ:TSLA) accelerating upwards, while software company Monday (MNDY) experienced a steep drop. The market has reacted to a mix of earnings... Full story

Yahoo Finance • 2 months ago

Edge AI Hardware Market Research Report 2025-2030 | Opportunities Expand with Generative AI Optimization, On-Device Visual Processors, and 5G-Enabled Ultra-Low Latency Applications

Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Edge AI Hardware Market by Device, Processor (CPU, GPU, and ASIC), Function, Power Consumption (Less than 1 W, 1-3 W, >3-5 W, >5-10 W, and More than 10 W), Vertical and Region - Global Forec... Full story

Yahoo Finance • 2 months ago

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical

Company Logo The Saudi Arabia OTC Artificial Tears Market is projected to reach USD 79.09 million by 2033, growing at a CAGR of 4.22% from 2025. Contributing factors include a rising elderly population, increased incidence of dry eye synd... Full story

Yahoo Finance • 2 months ago

Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon

Company Logo The Saudi Arabia Vision Care Market is projected to grow from US$ 899.58 million in 2024 to US$ 1.29 billion by 2033, driven by a CAGR of 4.11% from 2025 to 2033. Key growth factors include an aging population, rising eye dis... Full story

Yahoo Finance • 2 months ago

Canada stocks lower at close of trade; S&P/TSX Composite down 0.40%

Investing.com – Canada stocks were lower after the close on Thursday, as losses in the Healthcare, REITs and Energy sectors led shares lower. At the close in Toronto, the S&P/TSX Composite fell 0.40%. The best performers of the session o... Full story